Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MACROPHAGE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
MACROPHAGE is a concept in neurodegeneration research. Key relationships include: co discussed, activates, regulates. Associated with ALZHEIMER, ALZHEIMER'S, ALZHEIMER'S DISEASE. Connected to 293 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | MACROPHAGE |
| Key Genes/Proteins | ABCA1, ABCA7, ACHE, AD, AIF1, AKT |
| Related Diseases | ALZHEIMER, ALZHEIMER'S, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS |
graph TD
MACROPHAGE["MACROPHAGE"]
MACROPHAGE -->|"activates"| glioblastoma["glioblastoma"]
MACROPHAGE -->|"regulates"| INFLAMMATORY_RESPONSE["INFLAMMATORY_RESPONSE"]
SQSTM1["SQSTM1"] -->|"expressed in"| MACROPHAGE
BECN1["BECN1"] -->|"expressed in"| MACROPHAGE
autophagy["autophagy"] -->|"regulates"| MACROPHAGE
LOX["LOX"] -->|"activates"| MACROPHAGE
P2RY12["P2RY12"] -->|"expressed in"| MACROPHAGE
TMEM119["TMEM119"] -->|"expressed in"| MACROPHAGE
GAIN["GAIN"] -->|"expressed in"| MACROPHAGE
MICROGLIA["MICROGLIA"] -->|"expressed in"| MACROPHAGE| Target | Relation | Type | Str |
|---|---|---|---|
| Axonal Loss | contributes_to | process | 0.95 |
| Cardiovascular Disease | involved_in | disease | 0.95 |
| Inflammatory Response | mediates | process | 0.92 |
| efferocytosis | involved_in | process | 0.92 |
| Multiple Sclerosis | contributes_to | disease | 0.90 |
| ConA-Induced Hepatitis | involved_in | disease | 0.90 |
| Atherosclerosis | associated_with | disease | 0.90 |
| IRON METABOLISM | involved_in | entity | 0.90 |
| Apoptotic Cell Clearance | mediates | process | 0.90 |
| Intracerebral Hemorrhage | involved_in | disease | 0.90 |
| ATHEROSCLEROSIS | contributes_to | entity | 0.90 |
| Inflammatory Pain Resolution | promotes | phenotype | 0.90 |
| Myocardial Fibrosis | involved_in | phenotype | 0.88 |
| cardiomyocyte hypertrophy | promotes | phenotype | 0.87 |
| Aneurysm | associated_with | disease | 0.85 |
| Coronary Heart Disease | associated_with | disease | 0.85 |
| Myocarditis | associated_with | disease | 0.85 |
| Peripheral Nerve Injury | involved_in | disease | 0.85 |
| neutrophil | associated_with | cell_type | 0.85 |
| Myocardial Infarction | involved_in | disease | 0.85 |
| Nerve Tissue Repair | involved_in | process | 0.85 |
| NLRP3 INFLAMMASOME | expressed_in | protein | 0.85 |
| Nerve Degeneration | mediates | process | 0.85 |
| P2RY12 | expressed_in | entity | 0.85 |
| Immune Response | involved_in | process | 0.85 |
| TREM2 | expressed_in | entity | 0.85 |
| INFLAMMATION | mediates | entity | 0.85 |
| Heart Failure | associated_with | disease | 0.85 |
| tubulointerstitial injury | associated_with | phenotype | 0.80 |
| NLRP3 | markers | gene | 0.70 |
| TRAF6 | markers | gene | 0.70 |
| RAGE | targets | gene | 0.70 |
| TREM2 | mediates | gene | 0.70 |
| RIPK1 | expresses | gene | 0.70 |
| PDGF | enhances | gene | 0.70 |
| RAGE | activates | gene | 0.70 |
| OLIGODENDROCYTES | expresses | cell_type | 0.70 |
| PERICYTES | activates | cell_type | 0.70 |
| OLIGODENDROCYTES | activates | cell_type | 0.70 |
| PI3K/AKT/MTOR | activates | pathway | 0.70 |
| WNT | regulates | gene | 0.70 |
| NFKB | activates | gene | 0.70 |
| PDGF | activates | gene | 0.70 |
| PERICYTE | activates | cell_type | 0.70 |
| P2RY12 | stabilizes | gene | 0.70 |
| OLIGODENDROCYTE | expresses | cell_type | 0.70 |
| STING | targets | gene | 0.70 |
| TREM2 | disrupts | gene | 0.70 |
| NOTCH | regulates | gene | 0.70 |
| STAT3 | markers | gene | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PARKINSON'S DISEASE | associated_with | disease | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | disease | 1.00 |
| MICROGLIA | associated_with | cell_type | 1.00 |
| NF-KB | associated_with | protein | 1.00 |
| IFN-γ | activates | entity | 0.90 |
| PAD4 | regulates | gene | 0.90 |
| CHRNA7 | expressed_on | gene | 0.90 |
| MICROGLIA | activates | cell_type | 0.90 |
| ANXA1 | modulates | protein | 0.90 |
| Piezo1 | modulates | gene | 0.90 |
| Glycolytic Reprogramming | expressed_in | process | 0.90 |
| MIR-369-3P | expressed_in | gene | 0.90 |
| TET1 | regulates | gene | 0.90 |
| HK2 | expressed_in | entity | 0.90 |
| MKRN2 | expressed_in | protein | 0.85 |
| CNS NICHE | modulates | entity | 0.85 |
| Proinflammatory Genetic Profile | associated_with | phenotype | 0.85 |
| APOE | regulates | gene | 0.85 |
| AKT | activates | gene | 0.82 |
| IL-6 | associated_with | gene | 0.82 |
| MTOR | activates | gene | 0.82 |
| PCTR1 | expressed_in | compound | 0.80 |
| Decursin | inhibits | drug | 0.80 |
| Annexin A1 | regulates | protein | 0.80 |
| PAD4 | associated_with | gene | 0.80 |
| TENASCINC | associated_with | protein | 0.80 |
| IL10 | regulates | entity | 0.80 |
| HIF1A | expressed_in | gene | 0.80 |
| SIRT6 | regulates | gene | 0.80 |
| Epsins | regulates | gene | 0.80 |
| IL13 | activates | gene | 0.80 |
| RAB7A | expressed_in | protein | 0.75 |
| UBIQUITIN | associated_with | protein | 0.74 |
| MICROGLIA | regulates | cell_type | 0.74 |
| CSF1R | expresses | gene | 0.70 |
| GFAP | activates | gene | 0.70 |
| IBA1 | activates | gene | 0.70 |
| APP | activates | gene | 0.70 |
| GRN | regulates | gene | 0.70 |
| ENDOTHELIAL | activates | cell_type | 0.70 |
| JAK | activates | gene | 0.70 |
| CX3CR1 | targets | gene | 0.70 |
| GRN | causes | gene | 0.70 |
| CGAS | interacts_with | gene | 0.70 |
| CX3CL1 | disrupts | gene | 0.70 |
| CX3CR1 | disrupts | gene | 0.70 |
| CX3CR1 | expresses | gene | 0.70 |
| CX3CL1 | targets | gene | 0.70 |
| FTD | regulates | disease | 0.70 |
| CR1 | activates | gene | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Mutant-dependent amplification is context-dependent and stro | 0.740 | neurodegeneration | Do pathogenic LRRK2 mutations amplify vo |
| Peripheral Monocyte/Macrophage Infiltration Mimicking Microg | 0.693 | neuroinflammation | What causes IBA1 low/negative microglia |
| IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral | 0.648 | neuroinflammation | How do B cells mechanistically orchestra |
| C1Q-Triggered NLRP3 Inflammasome Assembly in Plaque Macropha | 0.640 | neuroinflammation | What are the specific molecular mechanis |
| MOG-IgG induces spinal cord demyelination through Fcγ recept | 0.560 | neuroinflammation | What are the specific pathophysiological |
| CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macr | 0.535 | neurodegeneration | How do perivascular cells specifically r |
| TREM2 on Perivascular Macrophages Senses Aβ and Drives SPP1 | 0.496 | neurodegeneration | How do perivascular cells specifically r |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| IL-10 deficiency and VLC ceramide accumulation in inflammatory bowel d | validation | inflammatory bowel disease | 0.900 | 0.00 | IL-10 knockout mice | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning MACROPHAGE in their description or question text
Score: 0.535 · neurodegeneration · 2026-04-22
## Mechanistic Overview CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macrophages, Triggering NF-κB-Dependent
Score: 0.496 · neurodegeneration · 2026-04-22
## Mechanistic Overview TREM2 on Perivascular Macrophages Senses Aβ and Drives SPP1 Upregulation Through CSF1R-Mediated